These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment. Chait A; Eckel RH Ann Intern Med; 2019 May; 170(9):626-634. PubMed ID: 31035285 [TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Update on the Chylomicronemia Syndrome. Goldberg RB; Chait A Front Endocrinol (Lausanne); 2020; 11():593931. PubMed ID: 33193106 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome. Chaudhry R; Viljoen A; Wierzbicki AS Expert Rev Clin Pharmacol; 2018 Jun; 11(6):589-598. PubMed ID: 29842811 [TBL] [Abstract][Full Text] [Related]
6. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1. Ahmad Z; Wilson DP J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947 [TBL] [Abstract][Full Text] [Related]
7. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome. Paquette M; Amyot J; Fantino M; Baass A; Bernard S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660 [TBL] [Abstract][Full Text] [Related]
8. Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Brunzell JD; Bierman EL Med Clin North Am; 1982 Mar; 66(2):455-68. PubMed ID: 7040847 [TBL] [Abstract][Full Text] [Related]
9. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. Baass A; Paquette M; Bernard S; Hegele RA J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of therapeutic plasma exchange in reducing the incidence of recurrent pancreatitis related to familial chylomicronemia. Fitts E; Lee PDK; Yates SG Transfusion; 2019 Nov; 59(11):3324-3328. PubMed ID: 31568575 [TBL] [Abstract][Full Text] [Related]
11. Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia. Guay SP; Paquette M; Taschereau A; Girard L; Desgagné V; Bouchard L; Bernard S; Baass A Atherosclerosis; 2024 May; 392():117489. PubMed ID: 38448342 [TBL] [Abstract][Full Text] [Related]
12. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Chyzhyk V; Brown AS Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756 [TBL] [Abstract][Full Text] [Related]
13. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis. Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873 [TBL] [Abstract][Full Text] [Related]
14. Severe hypertriglyceridemia: Existing and emerging therapies. Malick WA; Do R; Rosenson RS Pharmacol Ther; 2023 Nov; 251():108544. PubMed ID: 37848164 [TBL] [Abstract][Full Text] [Related]
15. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature. Ito MK Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750 [TBL] [Abstract][Full Text] [Related]
16. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study. Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188 [TBL] [Abstract][Full Text] [Related]
17. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment. Gallo A; Béliard S; D'Erasmo L; Bruckert E Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of therapies for chylomicronemia. Shamsudeen I; Hegele RA Expert Rev Clin Pharmacol; 2022 Apr; 15(4):395-405. PubMed ID: 35762447 [TBL] [Abstract][Full Text] [Related]
20. Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case report. Tünnemann-Tarr A; Scharnagl H; Katzmann JL; Stürzebecher P; Laufs U Medicine (Baltimore); 2021 Oct; 100(42):e27573. PubMed ID: 34678899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]